Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dynamics of Procalcitonin and C-Reactive Protein Associated With Respiratory Physiotherapy in Critically Ill Patients With Pneumonia

NCT07909616 is registered in ClinicalTrials.gov with Hospital H+ Queretaro as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07909616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Dynamics of Procalcitonin and C-Reactive Protein Associated With Respiratory Physiotherapy in Critically Ill Patients With Pneumonia
Lead sponsor
Hospital H+ Queretaro
Phase
Observational
Overall status
Recruiting
Start date
September 8, 2026
Completion date
December 1, 2026
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

Arms

As registered; 2 arms.

  • Prospective Intervention Group Protocolized Respiratory Physiotherapy Program

    Adult patients admitted to the ICU with a confirmed diagnosis of pneumonia who receive an individualized, protocolized respiratory physiotherapy program (including high-frequency chest wall oscillation, intrapulmonary acoustic percussion, positive expiratory pressure, and inspiratory muscle training) alongside standard care.

  • Historical Control Group

    Retrospective historical cohort of adult patients admitted to the ICU with pneumonia who received standard medical, ventilatory, and nursing care without specialized protocolized respiratory physiotherapy.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Adjusted Change in Procalcitonin (PCT) Levels Baseline, Day 3, Day 7, and up to ICU discharge (approx. 48 hours to length of stay)

    Evaluates the adjusted change in serum procalcitonin levels from baseline across standardized time points (Day 3, Day 7, and ICU discharge) between the prospective intervention cohort and the historical control group using generalized linear mixed models (GLMM) with restricted cubic splines.

Lead sponsor's other trials

Hospital H+ Queretaro, most recent start first.

Similar trials

Same condition (Critical Illness) and phase, most recent start first.